Nuclear translocation of GPS2 promotes activation of hepatic stellate cells by fatty acid oxidation pathway
Life Sciences · 2026-09 · 401 · 124529
DOI: 10.1016/j.lfs.2026.124529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-09. Verfasst von Haiqin Hong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, Ch…. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Fatty Acids, Cell Nucleus, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui Medical University.
Abstract (Originalsprache)
AIMS To investigate the role of G protein pathway suppressor 2 (GPS2) nuclear translocation in hepatic stellate cell (HSC) activation and its underlying mechanisms in liver fibrosis. MATERIALS AND METHODS RNA sequencing (RNA-seq) was performed to analyze differential gene expression among experimental groups. Fatty acid oxidation (FAO) was evaluated using FAO Blue staining. Co-immunoprecipitation (Co-IP) assays were conducted to investigate the interaction between GPS2 and its potential binding partners. In addition, HSC activation was induced by PDGF-BB, and cell proliferation, activation markers, and mitochondrial FAO levels were systematically assessed. KEY FINDINGS GPS2 nuclear translocation was significantly increased during HSC activation. Inhibition of GPS2 nuclear translocation attenuated liver fibrosis and reduced HSC activation. Mechanistically, blocking GPS2 nuclear translocation weakened its interaction with PPARα. PPARα was found to regulate mitochondrial FAO, which in turn promoted HSC proliferation and activation. Suppression of PPARα reduced FAO and alleviated HSC activation. SIGNIFICANCE This study identifies a novel mechanism whereby GPS2 nuclear translocation promotes HSC activation through interaction with PPARα and regulation of mitochondrial FAO. Targeting GPS2 nuclear translocation may represent a potential therapeutic strategy for liver fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China; Department of Clinical Laboratory, The Second Hospital of Anhui M…
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China.
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China. Electronic address: huangyan_@ahmu.edu.cn.
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmaceutical Sciences, Anhui Medical University, Hefei 230032, China. Electronic address: luweili2025@ahmu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Anhui Medical University
Zitieren
APA
Hong, H., Wang, L., Lu, M., An, Z., Shi, Y., Deng, Q., Wu, J., Wang, B., Lu, J., Li, M., Huang, Y., Lu, W., & Wu, F. (2026). Nuclear translocation of GPS2 promotes activation of hepatic stellate cells by fatty acid oxidation pathway. Life Sciences, 401, 124529. https://doi.org/10.1016/j.lfs.2026.124529
Vancouver
Hong H, Wang L, Lu M, An Z, Shi Y, Deng Q, et al. Nuclear translocation of GPS2 promotes activation of hepatic stellate cells by fatty acid oxidation pathway. Life Sciences. 2026;401:124529. doi:10.1016/j.lfs.2026.124529
BibTeX
@article{Hong2026,
author = {Hong, Haiqin and Wang, Li and Lu, Muran and An, Ziyi and Shi, Yanxia and Deng, Qi and Wu, Jingjing and Wang, Benwei and Lu, Jialu and Li, Mengjun and Huang, Yan and Lu, Weili and Wu, Fanrong},
title = {Nuclear translocation of GPS2 promotes activation of hepatic stellate cells by fatty acid oxidation pathway},
journal = {Life Sciences},
year = {2026},
volume = {401},
pages = {124529},
doi = {10.1016/j.lfs.2026.124529}
}
EUVIMED